Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Enterprise Value: 2011-2025

Historic Enterprise Value for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to $238.6 million.

  • Fennec Pharmaceuticals' Enterprise Value rose 147.21% to $238.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $170.5 million, marking a year-over-year increase of 1649.65%. This contributed to the annual value of $146.7 million for FY2024, which is 48.62% down from last year.
  • As of Q3 2025, Fennec Pharmaceuticals' Enterprise Value stood at $238.6 million, which was up 13.31% from $210.5 million recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Enterprise Value registered a high of $285.6 million during Q4 2023, and its lowest value of $96.5 million during Q3 2024.
  • For the 3-year period, Fennec Pharmaceuticals' Enterprise Value averaged around $191.7 million, with its median value being $206.5 million (2023).
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 48.62% in 2024, then spiked by 147.21% in 2025.
  • Over the past 5 years, Fennec Pharmaceuticals' Enterprise Value (Quarterly) stood at $220.6 million in 2021, then fell by 17.79% to $228.1 million in 2022, then rose by 25.19% to $285.6 million in 2023, then slumped by 48.62% to $146.7 million in 2024, then surged by 147.21% to $238.6 million in 2025.
  • Its Enterprise Value was $238.6 million in Q3 2025, compared to $210.5 million in Q2 2025 and $145.4 million in Q1 2025.